Tepha, Inc.

16 articles about Tepha, Inc.

• BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration

  7/27/2021

  BD, a leading global medical technology company, announced it has acquired Tepha, Inc., a leading developer and manufacturer of a proprietary resorbable polymer technology.

• Tepha Inc. Announces the Presentation of Pre-Clinical and Clinical Data on the Use of P4HB™ Regenerative Scaffolds In Urogynecology

  9/25/2019

  In 2016 Tepha initiated an integrated bench, pre-clinical and clinical testing program in collaboration with urogynecological thought leaders on three continents, in an effort to design and develop P4HB scaffolds for the surgical treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse

• Tepha Inc. Announces Initiation of Clinical Evaluation of P4HB™ Regenerative Scaffold for Stress Urinary Incontinence

  2/27/2019

  The study was initiated in Cape Town, South Africa in partnership with the Pelvic Floor Foundation of South Africa and the University of Cape Town. 

• Galatea Surgical, Subsidiary of Tepha Inc., Announces Publication of GalaFLEX™ Post-Market Study Results

  5/1/2018

  Galatea Surgical announced the publication of a clinical study investigating the clinical performance of its GalaFLEX™ Surgical Scaffold when used in elective mastopexy for soft tissue support.

• Tepha Announces Regenerative Medicine Recent Developments and R&D Initiatives

  11/8/2017

  Tepha announced today recent developments and R & D initiatives in the field of regenerative medicine scaffolds for the repair or replacement of compromised human tissue.

• Tepha, Inc. Subsidiary, Galatea Surgical, Announces The Launch Of GalaFORM 3D Surgical Scaffold

  4/27/2017

• Tepha, Inc. Subsidiary, Galatea Surgical, Announces Launch Of GalaSHAPE 3D Surgical Scaffold

  3/29/2017

• Tepha, Inc. Subsidiary, Galatea Surgical, Announces Presentation Of GalaFLEX Surgical Scaffold Clinical Data At London Breast Meeting

  11/16/2016

• Tepha, Inc. Announces Buy-Out Of Its Royalty Obligation To Metabolix

  10/11/2016

• Funding Round Nets $11.3 Million for Absorbable Medical Device Maker Tepha, Inc.

  3/20/2012

• Tepha, Inc. Partner Launches Novel Monofilament Absorbable Suture Utilizing Tepha's Proprietary Biomaterial

  5/1/2009

• Tepha, Inc. Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer

  7/24/2008

• Tornier and Tepha, Inc. Announce Human Usage of Sutures Derived from New Class of Resorbable Polymers

  4/17/2008

• Tepha, Inc. Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers

  4/17/2008

• Tepha, Inc. Announces $10.7 Million Venture Capital Financing

  6/6/2007

• Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers

  4/9/2007